Notably, by immunochemistry analysis, there was a significantly lower count of CD4+ and CD8+ tumor-infiltrated lymphocytes in the VTT samples compared with their primary tumor tissues from our cohort (Figures 6F, G). This evidence concerns the gene CD8A and neoplasm.